Darae Ko

Cardiology
801 Massachusetts Ave
Boston, MA 02118

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications

Correction to: 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Correction to: 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Journal: Circulation
Published: August 03, 2026

Prioritizing Discovery and Advancements in Arrhythmia Therapies: NIH/NHLBI Workshop.

Prioritizing Discovery and Advancements in Arrhythmia Therapies: NIH/NHLBI Workshop.

Journal: JACC. Clinical electrophysiology
Published: April 02, 2026

Response to Comment on Park et al. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147-151.

Response to Comment on Park et al. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147-151.

Journal: Diabetes care
Published: March 20, 2026

2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Journal: Circulation
Published: January 21, 2026

Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy.

Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy.

Journal: Neurology
Published: December 29, 2025

Frailty and the efficacy and safety of surgical versus endovascular revascularization: post-hoc analysis of the BEST-CLI trial.

Frailty and the efficacy and safety of surgical versus endovascular revascularization: post-hoc analysis of the BEST-CLI trial.

Journal: The British journal of surgery
Published: December 08, 2025

Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial.

Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial.

Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025

Post-Stroke Atrial Fibrillation Detection With Insertable Cardiac Monitors in Patients With Dementia and Frailty.

Post-Stroke Atrial Fibrillation Detection With Insertable Cardiac Monitors in Patients With Dementia and Frailty.

Journal: Journal of the American Geriatrics Society
Published: September 26, 2025

Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study.

Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study.

Journal: Circulation. Cardiovascular quality and outcomes
Published: August 27, 2025

Patterns of Oral Anticoagulant Use in Atrial Fibrillation Following Transition to Long-Term Care.

Patterns of Oral Anticoagulant Use in Atrial Fibrillation Following Transition to Long-Term Care.

Journal: Journal of the American Geriatrics Society
Published: August 12, 2025

Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Journal: Circulation
Published: June 23, 2025

Correction to: 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Correction to: 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Journal: Circulation
Published: June 23, 2025
Showing 1-12 of 84

Last Updated: 09/26/2026